The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Circulating tumor cells and detection of EGFR mutation in cell-free tumor DNA in blood plasma in metastatic non-small cell lung cancer with EGFR mutation.
K. Isobe
No relevant relationships to disclose
Y. Hata
No relevant relationships to disclose
S. Sakaguchi
No relevant relationships to disclose
K. Sato
No relevant relationships to disclose
K. Sugino
No relevant relationships to disclose
G. Sano
No relevant relationships to disclose
S. Sakamoto
No relevant relationships to disclose
Y. Takai
No relevant relationships to disclose
K. Shibuya
No relevant relationships to disclose
K. Takagi
No relevant relationships to disclose
S. Homma
No relevant relationships to disclose